3Bozkurt B, Mann DL. Use of biomarkers in the management of heart failure: are we there yet [ J] ? Circulation, 2003,107 (9): 1231- 1233.
4Seino Y, Ogawa A, Yamashita T, et al. Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure [ J ]. Eur J Heart Fail, 2004,6(3) :295-300.
5Bhatia V, Nayyar P, Dhindsa S. Brain natriuretic peptide in diagnosis and treatment of heart failure [ J ]. Postgrad Med, 2003,49 (2) : 182-185.
7Groenning BA, Nilsson JC, Sondergaard L, et al. Detection of left enlargement and impaired systolic function with plasma N-terminal probrain natariuretic peptide concentrations [ J ]. Am Heart J, 2002,143 (5) :923-929.
9Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of Chronic heart failure in the adult [ J ]. Circulation, 2005,112 (12) : e154-e235.
3Hunt PJ, Richards AM, Nicholls MG, et al. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol, 1997, 47:287 -296.
4Yeo KT , Wu AH , Apple FS, et al. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta, 2003, 338:107-115.
5Cowie MR, Struthers AD, Wood DA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet, 1997, 350:1349-1353.
6McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet, 1998, 351:9-13.
7Pfister R, Scholz M, Wielckens K, et al. Use of NT-proBNP in routing testing and comparison to BNP. Eur J Heart Fail, 2004, 6:289 -293.
8Seino Y, Ogawa A, Yamashita T, et al. Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. Eur J Heart Fail, 2004, 6:295-300.
9McCullough PA, Sandberg KR. B-type natriuretic peptide and renal disease. Heart Fail Rev, 2003, 8:355 -358.
10Richards AM , Nicholls MG , Yandle TG , et al. Plasma N-terminal pro-brain natriureitc peptide and adrenomedullin: new neurohormonal predictors of left ventriculation function and prognosis after myocardial infarction. Circulation, 1998, 97:1921-1929.
